CYTOMEGALOVIRUS (CMV)
Clinical trials for CYTOMEGALOVIRUS (CMV) explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS (CMV) trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS (CMV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for transplant patients: drug targets Drug-Resistant CMV
Disease control Recruiting nowThis study tests a drug called maribavir in 20 Chinese adults who had a stem cell or organ transplant and have a CMV infection that no longer responds to standard treatments. The main goal is to see if maribavir is safe and tolerable, and also how well it clears the virus and pre…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 08:51 UTC
-
New drug aims to tame virus threat in modern cancer treatments
Disease control Recruiting nowThis study tests whether the drug maribavir can safely lower levels of cytomegalovirus (CMV) in people with blood cancers like lymphoma or multiple myeloma who are receiving bispecific antibody therapy. About 20 adults will receive maribavir, and researchers will measure how many…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New drug for Post-Transplant CMV infection under Real-World review
Disease control Recruiting nowThis study looks at how safe and effective the drug LIVTENCITY (Maribavir) is for treating cytomegalovirus (CMV) infection in adults who have had an organ or stem cell transplant. About 168 participants in South Korea will be followed for 20 weeks during their routine care. The g…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
New study tracks real-world use of maribavir for post-transplant CMV
Disease control Recruiting nowThis study follows 75 adults in Belgium who have had a stem cell or solid organ transplant and developed a CMV infection. Researchers will watch how doctors use the drug maribavir and how well it clears the virus, including side effects and whether the infection comes back. Parti…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
New study aims to stop a common virus threat after kidney transplant
Disease control Recruiting nowThis study tests two different approaches to prevent cytomegalovirus (CMV) infection in kidney transplant patients who are at high risk because the donor had CMV but the recipient did not. One group will take daily antiviral medicine for 200 days, while the other group will have …
Matched conditions: CYTOMEGALOVIRUS (CMV)
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for transplant patients with stubborn CMV infection
Disease control Recruiting nowThis study in Japan tracks 250 organ or stem cell transplant patients whose CMV infection did not get better with standard treatments. Patients take Maribavir tablets as part of their normal care, and doctors watch for side effects and check if the virus clears from the blood ove…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Sponsor: Takeda • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New study reviews maribavir safety for kidney patients with Post-Transplant CMV
Knowledge-focused Recruiting nowThis study reviews medical records of about 10 adults who had a transplant and developed a difficult-to-treat CMV infection along with severe kidney disease or kidney failure. Researchers want to see how safe the drug maribavir is for these patients. The study does not change the…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 26, 2026 08:34 UTC